We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The latest reproduction number (R) and growth rate of coronavirus (COVID-19).
How to use an interrupted time series to evaluate your digital health product.
This page provides details about DSIT's portfolio of AI assurance techniques and how to use it.
How to use a quasi-experimental study to evaluate your digital health product.
This guidance provides information on Acute Respiratory Infections (ARIs) in higher-risk settings.
Information for manufacturers of medical devices on post-market surveillance, reporting adverse incidents and field safety corrective actions to the MHRA.
How a product complies with EU safety, health and environmental requirements, and how to place a CE marking on your product.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Get help and extra support when dealing with HMRC if you have additional needs - for example you have a disability or health condition, if English is not your first language or if you’re experiencing domestic abuse or financial hardship.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).